Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-10

Clinical Trial Update: Sirolimus Injections for Autoimmune Scleritis [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating sirolimus injections for autoimmune scleritis has completed phases 1 and 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sirolimus (Sirolimus)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Scleritis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-06-10